Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

BACKGROUND: The preventive effect that tenofovir/emtricitabine (FTC) could have against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human immunodeficiency virus-negative people is unknown. The objective of this study was to analyze the seroprevalence and clinical manifestations o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayerdi, Oskar, Puerta, Teresa, Clavo, Petunia, Vera, Mar, Ballesteros, Juan, Fuentes, Manuel Enrique, Estrada, Vicente, Rodríguez, Carmen, Del Romero, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543639/
https://www.ncbi.nlm.nih.gov/pubmed/33200081
http://dx.doi.org/10.1093/ofid/ofaa455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543639/
https://www.ncbi.nlm.nih.gov/pubmed/33200081
http://dx.doi.org/10.1093/ofid/ofaa455

Ejemplares similares